chr8-78697446-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016010.3(ZC2HC1A):c.544A>G(p.Thr182Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,457,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016010.3 missense
Scores
Clinical Significance
Conservation
Publications
- epidermodysplasia verruciformisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- epidermodysplasia verruciformis, susceptibility to, 5Inheritance: AR Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000810 AC: 2AN: 246926 AF XY: 0.0000150 show subpopulations
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1457452Hom.: 0 Cov.: 30 AF XY: 0.00000414 AC XY: 3AN XY: 725042 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.544A>G (p.T182A) alteration is located in exon 6 (coding exon 6) of the ZC2HC1A gene. This alteration results from a A to G substitution at nucleotide position 544, causing the threonine (T) at amino acid position 182 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at